These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 416450)

  • 21. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P
    Arch Monaldi; 1972; 27(4):403-17. PubMed ID: 4217597
    [No Abstract]   [Full Text] [Related]  

  • 22. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on patients with primary drug resistance of the Mycobacterium tuberculosis].
    Prosvirnov KP; Korol' II; Dobrovol'skaia GI
    Probl Tuberk; 1972; 50(1):82-4. PubMed ID: 4622059
    [No Abstract]   [Full Text] [Related]  

  • 24. [Incidence of drug resistance of Mycobacterium tuberculosis].
    Terentieva AS
    Vrach Delo; 1979 Mar; (3):28-30. PubMed ID: 109992
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current data on primary resistance in pulmonary tuberculosis in adults in France. 2d survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966].
    Canetti G; Kreis B; Thibier R; Gay P; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1967 Jun; 31(4):433-74. PubMed ID: 4974609
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of pulmonary tuberculosis patients with primary drug resistant Mycobacterium tuberculosis].
    Protopopova NM; Bessonova GS; Cherednichenko LP
    Probl Tuberk; 1987; (1):27-30. PubMed ID: 3104897
    [No Abstract]   [Full Text] [Related]  

  • 28. [A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Part 1. Comparison of results in 1977 with those in 1957, '59, '61, '63, '66, '69 and '72 (author's transl)].
    Kekkaku; 1979 Nov; 54(11):515-22. PubMed ID: 118298
    [No Abstract]   [Full Text] [Related]  

  • 29. [Resistance of the strains of Mycobacterium tuberculosis isolated in the laboratory of the Institute for Tuberculosis and Pulmonary Diseases of Serbia (author's transl)].
    Davidović C; Vanić D; Panjević T; Knezević Z
    Plucne Bolesti Tuberk; 1979; 31(3-4):130-2. PubMed ID: 119979
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mycobacterial resistance in patients during their 1st hospitalization].
    Iuliano A
    Arch Monaldi; 1974; 29(5-6):483-90. PubMed ID: 4219725
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M; Czajka-Kropaczek L; Ciechanowska A
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary resistance to antitubercular drugs].
    Caminero Luna JA
    Med Clin (Barc); 1989 Jun; 93(1):30-6. PubMed ID: 2505005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
    Vinik LK; Konjicija A; Sutić N; Psorn-Rajs A; Matić M; Arslanagić N
    Plucne Bolesti; 1988; 40(1-2):32-5. PubMed ID: 3141940
    [No Abstract]   [Full Text] [Related]  

  • 36. [Laboratory data on pulmonary tuberculosis of recent vertification].
    Gelli G; Malaguzzi Valeri F
    G Pneumol; 1970 Dec; 14(4):228-36. PubMed ID: 5005067
    [No Abstract]   [Full Text] [Related]  

  • 37. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF
    Probl Tuberk; 1972; 50(8):20-5. PubMed ID: 4626690
    [No Abstract]   [Full Text] [Related]  

  • 39. Susceptibility of tubercle myobacteria to antibacterial drugs and its importance for the clinical course of tuberculosis.
    Radanov R; Dobrev P; Kalfin E
    Nauchni Tr Vissh Med Inst Sofiia; 1965; 44(5):27-35. PubMed ID: 4223179
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.